A Phase 2a, Randomised, Double Blind, Placebo-Controlled Study of IMR-687 in Adult Patients with Sickle Cell Anaemia (Homozygous HbSS or Sickle-B thalassemia.
Administered By
Awarded By
Contributors
- Shah, Nirmish Ramesh Principal Investigator
Start/End
- November 12, 2019 - September 30, 2020